Assyro AI

Orange Book product · Generic (ANDA)

MYCOPHENOLATE SODIUM

MYCOPHENOLATE SODIUM

Generic (ANDA)ANDA 214376TE ABRX YICHANG HUMANWELL
View MYCOPHENOLATE SODIUM familyOpen on FDA Orange Book

At a glance

Feb 10, 2021

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Feb 10, 2021

    5 yr 5 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

MYCOPHENOLATE SODIUM

Strength

EQ 180MG BASE

Dosage form

TABLET, DELAYED RELEASE

Route

ORAL

TE code

AB

Application

ANDA 214376

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of MYCOPHENOLATE SODIUM

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo